Table 6. Effect of the intervention on CMAM enrollment, treatment, and recovery outcomes for AM episodes in the longitudinal study.
| Comparison | Intervention | Δa (pp) | 95% CI | P value | |
|---|---|---|---|---|---|
| AM episodes | n = 1,401 | n = 1,275 | |||
| Enrolled in CMAM | 424 (30%) | 398 (31%) | 0.32 | −6.2 to 6.8 | 0.92 |
| n = 424 | n = 398 | ||||
| Treatment coverage (primary outcome)b | 93 (22%) | 118 (30%) | 7.7 | −1.2 to 17 | 0.090* |
| Treatment initiatedc | 239 (56%) | 276 (69%) | 13 | 1.3–24 | 0.029 |
| Recovery within 3 months after enrollment | 350 (83%) | 328 (82%) | −0.15 | −6.3 to 6.0 | 0.96 |
| Length of enrolled episodes, days | 73 ± 61 | 67 ± 51 | −5.9e | −15 to 3.3 | 0.21 |
| MAM episodes | n = 1,143 | n = 1,021 | |||
| Enrolled in CMAM | 338 (30%) | 318 (31%) | 1.1 | −5.8 to 8.0 | 0.76 |
| n = 338 | n = 318 | ||||
| MAM treatment coverageb | 40 (12%) | 61 (19%) | 7.0 | −0.39 to 14 | 0.064 |
| MAM treatment initiatedc | 123 (37%) | 155 (49%) | 12 | 0.090–24 | 0.048 |
| Recovery within 3 months after enrollment | 301 (89%) | 280 (88%) | −0.74d | −6.9 to 5.4 | 0.81 |
| Length of enrolled episodes, days | 57 ± 48 | 56 ± 40 | −1.3e | −11 to 8.3 | 0.79 |
| SAM episodes | n = 370 | n = 329 | |||
| Enrolled in CMAM | 131 (35%) | 119 (36%) | 1.1 | −11 to 13 | 0.85 |
| n = 131 | n = 119 | ||||
| SAM treatment coverageb | 15 (11%) | 14 (12%) | 0.42 | −9.5 to 10 | 0.93 |
| SAM treatment initiatedc | 47 (36%) | 51 (43%) | 5.7d | −8.9 to 20 | 0.44 |
| Recovery within 3 months after enrollment | 99 (76%) | 88 (74%) | −1.7 | −15 to 11 | 0.80 |
| Length of enrolled episodes, days | 75 ± 60 | 75 ± 51 | −0.37e | −19 to 18 | 0.97 |
Data are n (%) or mean ± SD.
*Not statistically significant when considering the critical P value calculated using the Benjamini–Hochberg method to account for multiple testing of primary outcomes (Pcritical = 0.016). ICCs for primary outcomes are presented in S1 Table.
aDifference between intervention and comparison group expressed in pp analyzed using a mixed-effect linear probability regression model with robust estimation of standard errors, with health center and child as random effects and child sex, child age at the start of the episode, whether the child was a first live birth, and month of inclusion as fixed effects, unless specified otherwise.
bTreatment coverage defined as the proportion of children with AM, MAM, or SAM that received continuous treatment from CMAM enrollment onwards over the total number of children with AM, MAM, or SAM, respectively, enrolled in CMAM.
cTreatment initiated implies that children with AM received either an MAM or SAM treatment, children with MAM received MAM treatment, and children with SAM received SAM treatment.
dChild random effect was removed from the model to solve convergence issues.
eDifference in mean episode length (days) between intervention and comparison group analyzed using a linear mixed-effects regression model with health center as random effect and child sex, child age at the start of the episode, whether the child was a first live birth, and month of inclusion as fixed effects. Child random effect was removed from the model to solve convergence issues.
Abbreviations: AM, acute malnutrition; CMAM, community management of AM; ICC, intracluster correlation coefficient; MAM, moderate AM; pp, percentage points; SAM, severe AM